Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: FDA Panel Rules Against NeurogesX Patch for HIV




 

Reuters (02.09.12) - Wednesday, February 15, 2012

A Food and Drug Administration panel of outside experts has ruled against using a product derived from chili peppers to treat neuropathic pain in people with HIV. The committee voted 12-0 that clinical data do not show substantial evidence that NeurogesX Inc.'s Qutenza is effective against pain in the extremities suffered by many HIV patients. The experts also voted 11-0, with one abstention, that the capsaicin patch's risk-benefit profile was not acceptable for use by persons with HIV.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in February 15, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.